BINDLEY-WESTERN DOES $481 MIL. SALES IN 1983
BINDLEY-WESTERN DOES $481 MIL. SALES IN 1983, up 11% from $433 mil. in 1982, the company reported in an interim year-end statement released Feb. 27. The chain whslr. said profit gains outpaced sales despite substantial inventory purchases at the end of 1983 and an unfavorable comparison to a reduced tax rate in 1982. Chairman William Bindley pointed out "that due to substantial investment tax credits in December, 1982, the company's fourth quarter 1982 effective tax rate was 31% compared to 47% in the 1983 quarter." Inventory purchases at the end of the year "had the effect of reducing 1983 fourth quarter income by 8› per share" or approximately $255,000. Bindley maintained that "the additional gross profit to be realized in 1984 from the December purchases would more than off-set the LIFO valuation impact on 1983 income." Bindley said that "aggressive sales efforts are producing better than anticipated results." The firm says "two new major customers" are beginning to use the whslr.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth